Related Experiment Video
Updated: Jun 8, 2026

Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies
Published on: June 2, 2011
[Classification and functional study of peripheral blood dendritic cells in patients with coronary artery disease
Xiao-Wen Tu1, Zhi-Liang Li, Ying-Feng Liu
1Department of Cardiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. tuxw1968@163.com
Insights
Peripheral blood dendritic cells (DCs) show altered numbers and function in coronary artery disease (CHD) patients, correlating with plaque instability and rupture. These changes in DCs and their subsets offer insights into coronary plaque development.
Area of Science:
- Immunology
- Cardiovascular Medicine
Context:
- Coronary artery disease (CHD) involves complex inflammatory processes.
- Dendritic cells (DCs) play a crucial role in immune regulation and inflammation.
- Understanding DC dynamics in CHD is vital for assessing disease progression.
Purpose:
- To quantitatively and functionally assess peripheral blood DCs and their subsets in CHD patients.
- To investigate the relationship between DC alterations and coronary plaque characteristics (stable, unstable, ruptured).
- To explore the functional capacity of DCs in modulating T-cell responses in CHD.
Summary:
- Patients with unstable or ruptured coronary plaques exhibited significantly higher percentages and numbers of DCs, myeloid DCs (mDCs), and mDC1s compared to those with stable plaques.
- Conversely, ruptured plaques were associated with decreased percentages and numbers of DCs, mDCs, mDC1s, and plasmacytoid DCs (pDCs).
- Enhanced T-cell proliferation and elevated levels of interleukin-2 and interferon-alpha were observed in patients with unstable and ruptured plaques, indicating heightened immune activation.
Impact:
- DC alterations and functional changes are linked to coronary plaque vulnerability in CHD.
- This study highlights DCs as potential biomarkers for assessing coronary plaque development and stability.
- Findings may inform future therapeutic strategies targeting immune dysregulation in CHD.
Objective:
To study the quantitative and functional changes of peripheral blood dendritic cells (DCs) and their subsets in the leukocyte population in patients with coronary artery disease (CHD) with different coronary artery plaques and explore the relation between DCs and coronary plaque development.
Methods:
Thirty CHD patients were divided into SAP (10 cases), UAP (10 cases) and ACS (10 cases) groups, with another 10 patients having negative result in coronary angiography as the control group. Intravascular ultrasound (IVUS) was performed to identify the nature of the plaques. The percentage and absolute number of peripheral blood DCs and DC subsets were measured by flow cytometry. The functional status of the DCs was analyzed by enzyme-linked immunosorbent assay (ELISA) and flow cytometry.
Results:
In the SAP group, IVUS found stable plaques in 8 cases and unstable plaques in 2 cases; in UAP group, 7 patients had unstable plaques, 2 had stable plaques, and 1 had plaque rupture. Plaque rupture, unstable plaques and stable plaques were found in 6, 3 and 1 patients in ACS group, respectively. In comparison with patients with stable plaques, those with unstable plaques had significantly increased percentages and number of DCs, mDCs and mDC1 (P<0.05), while the mDC2s and pDCs showed no obvious difference between them (P>0.05). The percentages and number of DCs, mDCs, mDC1s and pDCs were significantly decreased in patients with ruptured plaques (P<0.05). In peripheral blood monouclear cells cultured for 7 days, the CD83 expression was significantly higher in unstable and rupture plaque groups than in stable plaque group, and no significant difference was found between stable plaque group and the control group (P>0.05). In unstable and rupture plaque groups, co-culture with 2x10(5)/ml DCs evoked strong proliferation of the T cells in comparison with the stable plaque group, but no difference was found between the stable plaque and the control groups (P>0.05). Significantly higher levels of interleukin-2 and interferon-alpha were detected in the supernatant of the mixed lymphocyte reaction in unstable and ruptured plaque groups than in stable plaque and control groups, without obvious difference between the latter two groups.
Conclusion:
The percentage and absolute number of peripheral blood DCs and their functional status suggest the alterations of the coronary artery plaques in CHD patients.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction

